DrugPatentWatch Database Preview
Akorn Company Profile
What is the competitive landscape for AKORN, and what generic alternatives to AKORN drugs are available?
AKORN has one hundred and sixty-eight approved drugs.
There is one US patent protecting AKORN drugs. There are three tentative approvals on AKORN drugs.
There are two patent family members on AKORN drugs in two countries and one hundred and eighty-three supplementary protection certificates in thirteen countries.
Summary for Akorn
| International Patents: | 2 |
| US Patents: | 1 |
| Tradenames: | 133 |
| Ingredients: | 122 |
| NDAs: | 168 |
| Patent Litigation for Akorn: | See patent lawsuits for Akorn |
| PTAB Cases with Akorn as petitioner: | See PTAB cases with Akorn as petitioner |
Drugs and US Patents for Akorn
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Akorn Inc | PILOCARPINE HYDROCHLORIDE | pilocarpine hydrochloride | SOLUTION;OPHTHALMIC | 204398-002 | Sep 27, 2017 | AT | RX | No | No | See Pricing | See Pricing | ||||
| Akorn | DESOXIMETASONE | desoximetasone | OINTMENT;TOPICAL | 201005-001 | Apr 24, 2014 | AB | RX | No | No | See Pricing | See Pricing | ||||
| Akorn | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 017486-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | See Pricing | See Pricing | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Akorn
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Akorn | ALFENTA | alfentanil hydrochloride | INJECTABLE;INJECTION | 019353-001 | Dec 29, 1986 | 4,167,574 | See Pricing |
| Akorn | SUFENTA PRESERVATIVE FREE | sufentanil citrate | INJECTABLE;INJECTION | 019050-001 | May 4, 1984 | 3,998,834 | See Pricing |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Akorn Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2008014036 | See Pricing |
| European Patent Office | 2043601 | See Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Akorn Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0477295 | C990043 | Netherlands | See Pricing | PRODUCT NAME: EPTIFIBATIDE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; NAT. REGISTRATION NO/DATE: EU/1/99/109/001 - EU/1/99/109/002 19990701; FIRST REGISTRATION: CH 54050, 54054 19970227 |
| 0350733 | SPC/GB03/034 | United Kingdom | See Pricing | PRODUCT NAME: MOXIFLOXACIN AND PHARMACEUTICALLY USABLE HYDRATES AND ACID ADDITION SALTS THEREOF AND THE ALKALI METAL, ALKALINE EARTH METAL, SILVER AND GUANIDINIUM SALTS OF THE UNDERLYING CARBOXYLIC ACIDS AND THE RACEMATES THEREOF; REGISTERED: DE 45263.00.00 19990621; UK PL 000 10/0291 20030313 |
| 2957286 | 122018000145 | Germany | See Pricing | PRODUCT NAME: PATIROMER SORBITEX CALCIUM IN ALLEN VOM GRUNDPATENT GESCHUETZTEN FORMEN; REGISTRATION NO/DATE: EU/1/17/1179 20170719 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
